Nexium (Esomeprazole Magnesium Trihydrate)

Nexium (esomeprazole) is used to manage acid‑related disorders by suppressing gastric acid production.

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining a higher gastric pH.
• Erosive esophagitis: promotes healing of inflamed esophageal tissue and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.
• Prevention of NSAID‑induced gastric ulcers: reduces ulcer risk in patients requiring long‑term non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

• Esomeprazole magnesium trihydrate irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers basal and stimulated gastric acid secretion, leading to an increase in gastric pH and relief of acid‑related symptoms.

Common and serious adverse reactions have been reported with esomeprazole use.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient and self‑limiting.
• Nausea: occasional, may improve with food.
• Abdominal pain: mild discomfort in the upper abdomen.
• Flatulence: increased intestinal gas.
• Constipation: occasional reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Stevens‑Johnson syndrome/toxic epidermal necrolysis: extensive skin detachment.
• Hepatic enzyme elevation: abnormal liver function tests.
• Hypomagnesemia: low serum magnesium with prolonged use.
• Interstitial nephritis: kidney inflammation presenting with reduced urine output.

When prescribing Nexium, clinicians should consider several safety precautions.

• Renal function: assess before initiating therapy, especially in severe impairment.
• Magnesium levels: monitor during long‑term treatment to prevent hypomagnesemia.
• Hepatic impairment: use with caution; dose adjustment may be required.
• Rebound acid hypersecretion: avoid abrupt discontinuation after prolonged use.
• Drug interactions: review concomitant medications that may alter gastric pH or esomeprazole metabolism.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Esomeprazole may alter the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole: reduced antifungal absorption.
• Atazanavir: markedly decreased antiviral exposure.
• Clopidogrel: diminished antiplatelet activation.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, monitor coagulation.
• Digoxin: possible increase in serum levels, observe for toxicity.